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Abstract
We report a case of sarcoidosis presenting initially as atrial fibrillation(AF). His response to 
anti-arrhythmic  treatment  strategy  was  suboptimal.  On  initiation  of  immunosuppressive 
therapy,  AF  was  better  controlled.  This  interesting  case  highlights  a  likely  link  between 
inflammation  and  pathogenesis  of  atrial  fibrillation.                                 
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Atrial fibrillation (AF) has been associated with acute inflammation, post operative states and 
intensive care settings, with documented higher levels of inflammatory markers. Cases of left 
atrial  tachycardia  with  sarcoidosis  [1],  a  chronic  inflammatory  state  have  been  reported, 
however a direct relation of AF to inflammation in this condition has not been shown. We 
would like to submit a case with sarcoidosis, whose intial presentation was an episode of AF. 
A 39 yr old Caucasian male presented with paroxysmal AF 2 years ago. After a failed trial of 
anti-arrhythmic  agents,  he  underwent  circumferential  ostial  and  segmental  pulmonary  vein 
isolation. However, AF recurred within six months, and subsequently he also had an episode of 
syncope. Since evaluation with 48-hour Holter monitor revealed episodes of sinus arrest, he 
was implanted a dual chamber permanent pacemaker. He was again treated with class III anti-
arrhythmic agents with no reduction in episodes of AF.  During this  presentation,  his chest 
radiography revealed lung infiltrates, and ECG showed prolonged PR interval, a rate related 
RBBB with left posterior hemiblock (trifascicular block) which later on persisted with sinus 
rhythm  in  the  physiologic  heart  rate  range.  (Figure  1).  He  underwent  computerized 
tomography  of  chest  revealing  multiple  systemic  lesions,  the  biopsy  of  which  revealed 
granulomas. A diagnosis of sarcoidosis was made and he was started on prednisone, which was 
noted subsequently to reduce AF burden on pacemaker interrogation. Since he showed clinical 
improvement, hydroxychloroquine was introduced as a steroid sparing agent with consequent 
further reduction in AF burden. (Figure 2) Withdrawal of prednisone (phase 4 in Figure 2) led 
to a slight increase in AF burden. The improvement in AF burden paralleled that in lungs as 
noted in serial CT scans of chest. One year after the diagnosis of sarcoidosis, he developed 
cardiomyopathy and had non-sustained ventricular tachycardia. A Gallium scan confirmed two 
areas  of  uptake  in  the  left  ventricle  –  anteroapical  septum  and  basal  septum  confirming 
sarcoidosis of the heart. In view of these findings, his pacemaker was upgraded to implantable 
cardioverter defibrillator. Also, his drug regimen has been changed to mycophenolate 1000 mg 
twice daily. This is a unique patient, where the presenting cardiac  symptoms  were  that  of  AF 
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and subsequently conduction system disease, ventricular tachycardia and cardiomyopathy due 
to sarcoidosis were seen. Also, improvement in AF burden paralleling clinical and pulmonary 
improvement was shown with anti-inflammatory drug management.
Figure 1: Twelve lead EKG revealing prolonged PR interval, left posterior hemiblock and RBBB. 
Figure 2:  Log of AF duration over the course of anti-inflammatory treatment                                      
1-Prednisone  20  mg  once  daily                                                               
2-Prednisone 5 mg once daily, hydroxychloroquine200 mg twice daily                                                   
3-Prednisone 40 mg every other day and hydroxychloroquine 200 mg twice daily                                           
4-hydroxychloroquine  200  mg  twice  daily                                                           
5-hydroxychloroquine  200  mg  twice  daily                                                      
6-Cardiomyopathy with positive gallium scan
Steroids and steroid sparing agents have been used to treat cardiac sarcoidosis.[2] While AV 
conduction blocks, ventricular tachycardia and cardiomyopathy are known associations, [3] AF 
is unusual secondary to sarcoidosis. Improvement in AF burden by anti-inflammatory agents in 
cardiac sarcoidosis has been shown for the first time in literature.                                             
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